Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells

被引:384
作者
Hofstra, CL [1 ]
Desai, PJ [1 ]
Thurmond, RL [1 ]
Fung-Leung, WP [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA
关键词
D O I
10.1124/jpet.102.046581
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The diverse physiological functions of histamine are mediated through distinct histamine receptors. Mast cells are major producers of histamine, yet effects of histamine on mast cells are currently unclear. The present study shows that histamine induces chemotaxis of mouse mast cells, without affecting mast cell degranulation. Mast cell chemotaxis toward histamine could be blocked by the dual H-3/H-4 receptor antagonist thioperamide, but not by H-1 or H-2 receptor antagonists. This chemotactic response is mediated by the H-4 receptor, because chemotaxis toward histamine was absent in mast cells derived from H-4 receptor-deficient mice but was detected in H-3 receptor-deficient mast cells. In addition, Northern blot analysis showed the expression of H-4 but not H-3 receptors on mast cells. Activation of H-4 receptors by histamine resulted in calcium mobilization from intracellular calcium stores. Both Galphai/o proteins and phospholipase C (PLC) are involved in histamine-induced calcium mobilization and chemotaxis in mast cells, because these responses were completely inhibited by pertussis toxin and PLC inhibitor 1-[6-[[17beta-3-methoxyestra-1,3,5 (10)-trien-17-yl] amino] hexyl]-1H-pyrrole-2,5-dione (U73122). In summary, histamine was shown to mediate signaling and chemotaxis of mast cells via the H-4 receptor. This mechanism might be responsible for mast cell accumulation in allergic tissues.
引用
收藏
页码:1212 / 1221
页数:10
相关论文
共 36 条
[1]
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma [J].
Amin, K ;
Lúdvíksdóttir, D ;
Janson, C ;
Nettelbladt, O ;
Björnsson, E ;
Roomans, GM ;
Boman, G ;
Sevéus, L ;
Venge, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2295-2301
[2]
Histamine inhibits tumor necrosis factor alpha release by mast cells through H-2 and H-3 receptors [J].
Bissonnette, EY .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (06) :620-626
[3]
G protein beta gamma subunits [J].
Clapham, DE ;
Neer, EJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :167-203
[4]
INCREASED NUMBERS OF MAST-CELLS IN BRONCHIAL-MUCOSA AFTER THE LATE-PHASE ASTHMATIC RESPONSE TO ALLERGEN [J].
CRIMI, E ;
CHIARAMONDIA, M ;
MILANESE, M ;
ROSSI, GA ;
BRUSASCO, V .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (06) :1282-1286
[5]
The establishment of a combined serum-free and serum-supplemented culture method of obtaining functional cord blood-derived human mast cells [J].
Dahl, C ;
Saito, H ;
Nielsen, HV ;
Schiotz, PO .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 262 (1-2) :137-143
[6]
Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis [J].
Dastych, J ;
Taub, D ;
Hardison, MC ;
Metcalfe, DD .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (05) :C1291-C1299
[7]
Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins [J].
Exton, JH .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :481-509
[8]
DYNAMICS OF MAST-CELLS IN THE NASAL-MUCOSA OF PATIENTS WITH ALLERGIC RHINITIS AND NONALLERGIC CONTROLS - A BIOPSY STUDY [J].
FOKKENS, WJ ;
GODTHELP, T ;
HOLM, AF ;
BLOM, H ;
MULDER, PGH ;
VROOM, TM ;
RIJNTJES, E .
CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (07) :701-710
[9]
Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics [J].
Gauvreau, GM ;
Lee, JM ;
Watson, RM ;
Irani, AMA ;
Schwartz, LB ;
O'Byrne, PM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) :1473-1478
[10]
Hill SJ, 1997, PHARMACOL REV, V49, P253